Swertia purpurascens
Swertia purpurascens · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Swertia purpurascens is a botanical species that has gained scientific interest due to its diverse range of biological activities. Research indicates that its various preparations, including aqueous, butanol, and chloroform extracts, possess significant medicinal potential. Specifically, the plant has demonstrated promising antifibrotic properties in recent studies. Furthermore, it is being investigated for its ability to influence insulin sensitivity and combat oxidative stress. The plant's bioactive compounds also show potential in addressing conditions related to malaria.
- Synonyms
- Swertia Pedicellata · Swertia Ciliata · 7 more
- Common names
- Not available
- Family
- Gentianaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Swertia purpurascens is a botanical species that is associated with several distinct taxonomic synonyms. Historically, this plant has been identified under various names within the Ophelia genus, including Ophelia ciliata and Ophelia dalhousieana. It is also documented as Ophelia purpurascens, which encompasses the specific variety known as Ophelia purpurascens var. ciliata. Furthermore, the name Ophelia teres serves as another recognized synonym for this particular plant. Understanding these overlapping classifications is essential for accurate botanical identification and research.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Swertia purpurascens belongs to the vast kingdom Plantae, showcasing the diverse beauty of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It further belongs to the order Gentianales, which helps scientists understand its evolutionary lineage. This plant is a distinguished member of the genus Swertia, a group defined by specific morphological traits. Finally, it is nested within the family Gentianaceae, highlighting its close botanical ties to other gentians.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Gentianaceae |
| Genus | Swertia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Swertia purpurascens is a versatile plant species with a wide geographical range spanning various Asian climates. In temperate regions, it can be found throughout China and Tibet, extending even into Western Asia and Afghanistan. Moving into tropical zones, the species thrives across the Indian Subcontinent, specifically within the lush landscapes of Assam. Its presence is also well-documented in the high-altitude environments of the East Himalaya. Finally, the plant maintains a significant distribution within the diverse terrain of Nepal.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Swertia purpurascens is a distinctive herb that grows as a self-supporting plant within its natural habitat. This species maintains a compact stature, typically reaching a maximum height of 0.48 meters. Depending on environmental conditions, the plant's growth often fluctuates between a minimum of 0.3 meters and 0.39 meters. Such consistent dimensions make it a manageable component of its local ecosystem. Understanding these specific physical characteristics helps botanists identify the plant accurately in the field.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Swertia purpurascens has demonstrated significant potential as a plant-based therapeutic agent due to its potent antifibrotic activity. Recent investigations using an in vitro model of oral submucous fibrosis show that the herb's xanthone-rich extract can effectively target the underlying mechanisms of the disease. Specifically, the extract was found to cause a dose-dependent reduction in TGF-β1 secretion, a key driver of fibroblast activation. Furthermore, the treatment successfully limited fibroblast proliferation and inhibited the contraction of the extracellular matrix. These findings suggest that Swertia purpurascens could serve as a valuable candidate for managing oral submucous fibrosis and other related fibrotic disorders.
Compounds
Conditions
Swertia purpurascens possesses a variety of therapeutic properties, including the ability to produce significant CNS stimulant actions through its total xanthones. The plant also demonstrates protective anti-hepatotoxic activity against carbon tetrachloride-induced toxicity in rat hepatocytes. Furthermore, it serves as a potent insulin-sensitizing modulator by regulating myogenic factors and GLUT4 expression. This species enhances muscle glucose uptake under oxidative stress conditions, performing similarly to known pharmaceutical agents. Finally, members of the Swertia genus, including various species utilized in traditional medicine, are documented for their use in treating malaria.
Preparations
Swertia purpurascens is prepared as an extract for various medicinal evaluations, including studies on its antifibrotic activity. In research involving multiple Swertia species, the plant is prepared as an aqueous extract which then undergoes sequential extraction. This process allows the plant to be prepared as hexane, chloroform, and butanol extracts for specific screening purposes. These diverse preparations of Swertia purpurascens are utilized to test protective effects against cellular toxicity and fibrosis. Consequently, the plant is prepared as an extract in several different chemical forms to study its therapeutic potential.